Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.483NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.483NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.181NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.181NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.181NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.113NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.113NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.113NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.594NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.594NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.594NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.328NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.328NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.328NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.145NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.145NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.145NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.547NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.547NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.547NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.247NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.247NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.247NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.205NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.205NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.110NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.110NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.110NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.434NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.434NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.434NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.181NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.181NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.181NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.6.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.6.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used